Visalytics
Visalytics
dismissed EB-2 (NIW) RFE Issued

Pharmacist

Telepharmacy Consulting Service · 2023-10-31

Decision Date
2023-10-31
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to establish a telepharmacy consulting service to provide necessary medicine and related education to underserved communities through telehealth innovations such as direct-to-consumer telepharmacy consulting work.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Partially Met

The AAO found the endeavor had substantial merit but failed to establish national importance.

Why This Petition Was Denied

The motion was dismissed because the petitioner failed to establish the national importance of the endeavor. The AAO found that the evidence, including an impact analysis report and support letters, did not demonstrate that the endeavor would have a substantial positive economic effect or broad health-related impacts commensurate with national importance.

Request for Evidence (RFE)

Unsuccessfully Addressed

The RFE requested evidence to establish the national interest waiver; the petitioner provided a project description and impact report which were found insufficient to show national importance.

RFE Targets
Substantial Merit and National Importance

Evidence

Evidence Types
Reference Letters Dependent

Similar Cases

Pharmacist

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2025-03-31
The petitioner proposes to operate a comprehensive pharmaceutical service providing online health services and pharmaceuticals to patients across the country. The endeavor focuses on healthcare outcomes for vulnerable populations, such as the elderly and those with chronic conditions, through medication dispensing and patient education.

Consultant

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
South Florida 2024-05-28
The petitioner proposes to launch a pharmaceutical consulting firm catering to medium and large firms, focusing on research, quality management systems, and regulatory procedures. He also intends to develop master formulations for chronic and neglected diseases with a focus on low-income communities.

Pharmacist

Healthcare

USCIS EB-2 (NIW) rfe dismissed
Texas 2024-04-19
The petitioner initially proposed to work as a pharmacist in community clinics. Later, she attempted to change her endeavor to establishing a medication management business for the elderly using a software application and a bracelet device.

Consultant

Healthcare

USCIS EB-2 (NIW) rfe dismissed
2024-09-23
The petitioner proposes to establish a consultancy specializing in telemedicine supply chain management. This endeavor aims to develop a novel telemedicine platform connecting patients with health professionals via kiosks, computers, tablets, and cell phones, primarily targeting rural communities, migrant populations, and individuals with mobility/transportation difficulties in Florida and Puerto Rico to eliminate access barriers and reduce healthcare costs.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Healthcare cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-10-31.

Browse all cases

At a Glance

Outcome dismissed
RFE Issued
Criteria Met 0 / 3
Evidence Types 1

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist